A detailed history of Perennial Investment Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Perennial Investment Advisors, LLC holds 3,352 shares of ABBV stock, worth $603,360. This represents 0.09% of its overall portfolio holdings.

Number of Shares
3,352
Previous 3,350 0.06%
Holding current value
$603,360
Previous $574,000 15.16%
% of portfolio
0.09%
Previous 0.08%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $327 - $398
2 Added 0.06%
3,352 $661,000
Q2 2024

Aug 09, 2024

SELL
$154.79 - $180.76 $41,328 - $48,262
-267 Reduced 7.38%
3,350 $574,000
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $28,927 - $32,960
181 Added 5.27%
3,617 $658,000
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $52,563 - $59,198
-382 Reduced 10.01%
3,436 $532,000
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $48,626 - $56,292
364 Added 10.54%
3,818 $569,000
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $4,902 - $6,101
37 Added 1.08%
3,454 $465,000
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $8,098 - $9,326
56 Added 1.67%
3,417 $544,000
Q4 2022

Feb 09, 2023

SELL
$138.31 - $165.87 $968 - $1,161
-7 Reduced 0.21%
3,361 $543,000
Q3 2022

Nov 09, 2022

BUY
$134.21 - $153.93 $43,215 - $49,565
322 Added 10.57%
3,368 $452,000
Q2 2022

Aug 10, 2022

SELL
$137.62 - $174.96 $9,633 - $12,247
-70 Reduced 2.25%
3,046 $468,000
Q1 2022

May 09, 2022

SELL
$131.98 - $163.75 $12,010 - $14,901
-91 Reduced 2.84%
3,116 $507,000
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $9,131 - $11,554
-85 Reduced 2.58%
3,207 $434,000
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $2,979 - $3,381
-28 Reduced 0.84%
3,292 $357,000
Q2 2021

Jul 29, 2021

SELL
$105.21 - $117.21 $23,777 - $26,489
-226 Reduced 6.37%
3,320 $374,000
Q1 2021

Apr 29, 2021

SELL
$102.3 - $112.62 $25,472 - $28,042
-249 Reduced 6.56%
3,546 $384,000
Q4 2020

Jan 22, 2021

BUY
$80.49 - $108.67 $52,801 - $71,287
656 Added 20.9%
3,795 $407,000
Q3 2020

Oct 26, 2020

BUY
$85.91 - $100.83 $6,700 - $7,864
78 Added 2.55%
3,139 $275,000
Q2 2020

Jul 16, 2020

BUY
$73.37 - $98.18 $5,135 - $6,872
70 Added 2.34%
3,061 $301,000
Q1 2020

Apr 29, 2020

BUY
$64.5 - $97.79 $10,642 - $16,135
165 Added 5.84%
2,991 $228,000
Q4 2019

Feb 07, 2020

BUY
$72.13 - $90.25 $203,839 - $255,046
2,826 New
2,826 $251,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Perennial Investment Advisors, LLC Portfolio

Follow Perennial Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perennial Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perennial Investment Advisors, LLC with notifications on news.